• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coronary artery calcium density progression: Should we measure it?

作者信息

Razavi Alexander C, Blumenthal Roger S, Al-Mallah Mouaz H, Al Rifai Mahmoud

机构信息

Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA, USA.

Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Atherosclerosis. 2024 Nov;398:118618. doi: 10.1016/j.atherosclerosis.2024.118618. Epub 2024 Oct 3.

DOI:10.1016/j.atherosclerosis.2024.118618
PMID:39379273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12174981/
Abstract
摘要

相似文献

1
Coronary artery calcium density progression: Should we measure it?冠状动脉钙化密度进展：我们应该测量它吗？
Atherosclerosis. 2024 Nov;398:118618. doi: 10.1016/j.atherosclerosis.2024.118618. Epub 2024 Oct 3.
2
Coronary artery calcium incidence and changes using direct plaque measurements: The MASALA study.冠状动脉钙发生率及直接斑块测量变化：MASALA 研究。
Atherosclerosis. 2022 Jul;353:41-46. doi: 10.1016/j.atherosclerosis.2022.05.006. Epub 2022 May 18.
3
The estimation of coronary artery calcium thickness by computed tomography angiography based on optical coherence tomography measurements.基于光相干断层成像术测量的计算机断层血管造影术估算冠状动脉钙厚度。
Heart Vessels. 2023 Nov;38(11):1305-1317. doi: 10.1007/s00380-023-02286-1. Epub 2023 Jul 9.
4
Coronary artery disease progression assessed by electron-beam computed tomography.
Am J Cardiol. 2001 Jul 19;88(2A):46E-50E. doi: 10.1016/s0002-9149(01)01767-2.
5
Evolving Role of Calcium Density in Coronary Artery Calcium Scoring and Atherosclerotic Cardiovascular Disease Risk.钙密度在冠状动脉钙化积分和动脉粥样硬化性心血管疾病风险中的作用演变。
JACC Cardiovasc Imaging. 2022 Sep;15(9):1648-1662. doi: 10.1016/j.jcmg.2022.02.026. Epub 2022 May 11.
6
Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition.他汀类药物治疗与冠状动脉粥样硬化斑块成分进展的关系。
JAMA Cardiol. 2021 Nov 1;6(11):1257-1266. doi: 10.1001/jamacardio.2021.3055.
7
The relationship between coronary artery calcium density and optical coherence tomography-derived plaque characteristics.冠状动脉钙密度与光学相干断层扫描成像斑块特征的关系。
Atherosclerosis. 2020 Oct;311:30-36. doi: 10.1016/j.atherosclerosis.2020.08.010. Epub 2020 Aug 29.
8
Impact of metabolic syndrome on the progression of coronary calcium and of coronary artery disease assessed by repeated cardiac computed tomography scans.通过重复心脏计算机断层扫描评估代谢综合征对冠状动脉钙化进展和冠状动脉疾病的影响。
Cardiovasc Diabetol. 2016 Jun 28;15:92. doi: 10.1186/s12933-016-0404-7.
9
Comparison of serial quantitative evaluation of calcified coronary artery plaque by ultrafast computed tomography in persons with and without obstructive coronary artery disease.通过超快速计算机断层扫描对有和无阻塞性冠状动脉疾病的人群进行钙化冠状动脉斑块的系列定量评估的比较。
Am J Cardiol. 1991 Jul 1;68(1):1-6. doi: 10.1016/0002-9149(91)90700-u.
10
Coronary Calcium Characteristics as Predictors of Major Adverse Cardiac Events in Symptomatic Patients: Insights From the CORE 320 Multinational Study.冠状动脉钙化特征对有症状患者主要不良心脏事件的预测价值：来自 CORE 320 多国研究的见解。
J Am Heart Assoc. 2019 Mar 19;8(6):e007201. doi: 10.1161/JAHA.117.007201.

本文引用的文献

1
Progression of coronary artery calcium density and major adverse cardiovascular events.
Atherosclerosis. 2024 Nov;398:118593. doi: 10.1016/j.atherosclerosis.2024.118593. Epub 2024 Sep 6.
2
Coronary artery calcium: from risk prediction to treatment allocation and clinical trials.冠状动脉钙化：从风险预测到治疗分配和临床试验。
Heart. 2023 Oct 26;109(22):1714-1721. doi: 10.1136/heartjnl-2022-321711.
3
Major Global Coronary Artery Calcium Guidelines.主要全球冠状动脉钙化指南。
JACC Cardiovasc Imaging. 2023 Jan;16(1):98-117. doi: 10.1016/j.jcmg.2022.06.018. Epub 2022 Sep 14.
4
Statin therapy for the primary prevention of cardiovascular disease: Pros.他汀类药物治疗用于心血管疾病的一级预防：优点。
Atherosclerosis. 2022 Sep;356:41-45. doi: 10.1016/j.atherosclerosis.2022.07.004. Epub 2022 Jul 14.
5
Evolving Role of Calcium Density in Coronary Artery Calcium Scoring and Atherosclerotic Cardiovascular Disease Risk.钙密度在冠状动脉钙化积分和动脉粥样硬化性心血管疾病风险中的作用演变。
JACC Cardiovasc Imaging. 2022 Sep;15(9):1648-1662. doi: 10.1016/j.jcmg.2022.02.026. Epub 2022 May 11.
6
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.依洛尤单抗联合高强度他汀治疗对急性心肌梗死患者冠状动脉粥样硬化的影响：PACMAN-AMI 随机临床试验。
JAMA. 2022 May 10;327(18):1771-1781. doi: 10.1001/jama.2022.5218.
7
Mean Versus Peak Coronary Calcium Density on Non-Contrast CT: Calcium Scoring and ASCVD Risk Prediction.平扫 CT 冠状动脉钙密度的均值与峰值：钙评分与 ASCVD 风险预测。
JACC Cardiovasc Imaging. 2022 Mar;15(3):489-500. doi: 10.1016/j.jcmg.2021.09.018. Epub 2021 Nov 17.
8
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.2021 加拿大心血管学会成人血脂异常管理指南：预防心血管疾病
Can J Cardiol. 2021 Aug;37(8):1129-1150. doi: 10.1016/j.cjca.2021.03.016. Epub 2021 Mar 26.
9
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction.美国国家脂质协会关于冠状动脉钙评分指导 ASCVD 风险降低的预防策略的科学声明。
J Clin Lipidol. 2021 Jan-Feb;15(1):33-60. doi: 10.1016/j.jacl.2020.12.005. Epub 2020 Dec 11.
10
Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium.他汀类药物治疗使用者与非使用者中冠状动脉钙化评分、面积和密度的预后价值：冠状动脉钙化协会
Atherosclerosis. 2021 Jan;316:79-83. doi: 10.1016/j.atherosclerosis.2020.10.009. Epub 2020 Oct 10.